Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 322
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05274880 | Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393 | ||
| NCT02186496 | Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg) | ||
| NCT06838286 | Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes | ||
| NCT01756937 | Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee | ||
| NCT03587558 | Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract | ||
| NCT03849339 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition | ||
| NCT05677438 | A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia | ||
| NCT05657574 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia | ||
| NCT03858725 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers | ||
| NCT05189288 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects | ||
| NCT06483243 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State. | ||
| NCT04987970 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg | ||
| NCT04673695 | A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 | ||
| NCT02588937 | Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients | ||
| NCT03067194 | The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients | ||
| NCT05881707 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg | ||
| NCT05634447 | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391 | ||
| NCT04952506 | Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers | ||
| NCT06399068 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions | ||
| NCT03211143 | A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects | ||
| NCT02685774 | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers | ||
| NCT04700709 | Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. | ||
| NCT03346187 | A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 | ||
| NCT01330563 | Drug-drug Interaction Study (CKD-501, Ketoconazole) | ||
| NCT02824874 | CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1) | ||
| NCT01630018 | Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial | ||
| NCT03034486 | The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930 | ||
| NCT01991145 | Allogeneic UCB Therapy With EPO in Children With CP | ||
| NCT06727396 | A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants | ||
| NCT03802162 | A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 | ||
| NCT04678388 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions | ||
| NCT01128322 | CKD-828 Primary Hypertension Trial(Dose-selection) | ||
| NCT05549401 | Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 | ||
| NCT05897216 | Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029 | ||
| NCT04627207 | A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers | ||
| NCT01684605 | Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers | ||
| NCT06942156 | Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea | ||
| NCT06974903 | Retrospective Observational Study on GERD Management in General Hospitals in Korea | ||
| NCT07358156 | A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants. | ||
| NCT02548286 | Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs | ||
| NCT04810676 | A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383. | ||
| NCT05193565 | Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients | ||
| NCT04471441 | Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients. | ||
| NCT06431477 | Efficacy and Safety of Telmisartan Compared With Losartan | ||
| NCT04830930 | A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers | ||
| NCT05741437 | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378 | ||
| NCT05566028 | The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes | ||
| NCT01341392 | Drug-drug Interaction Study(CKD-501, Amlodipine) | ||
| NCT07304687 | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers | ||
| NCT07258745 | Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants |
